Private Advisor Group, LLC Vericel Corp Transaction History

Private Advisor Group, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$22.88 - $39.45 $133,916 - $230,900	-5,853 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$31.69 - $43.29 $3,961 - $5,411	125 Added 2.18%	5,853 $224,000
Q4 2021 Feb 10, 2022	SELL	$35.2 - $52.6 $410,009 - $612,684	-11,648 Reduced 67.03%	5,728 $225,000
Q3 2021 Oct 14, 2021	BUY	$46.35 - $59.75 $451,819 - $582,443	9,748 Added 127.79%	17,376 $847,000
Q2 2021 Aug 12, 2021	SELL	$47.2 - $67.81 $172,563 - $247,913	-3,656 Reduced 32.4%	7,628 $400,000
Q1 2021 Apr 22, 2021	BUY	$30.93 - $59.48 $88,954 - $171,064	2,876 Added 34.21%	11,284 $627,000
Q4 2020 Apr 01, 2021	BUY	$18.53 - $31.5 $155,800 - $264,852	8,408 New	8,408 $260,000
Q3 2020 Nov 02, 2020	SELL	$14.68 - $19.12 $77,070 - $100,380	-5,250 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$8.5 - $15.82 $44,625 - $83,055	5,250 New	5,250 $73,000

277

48.4M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.6B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.